A carregar...
Epoetin beta pegol ameliorates flow‐mediated dilation with improving endothelial nitric oxide synthase coupling state in nonobese diabetic rats
BACKGROUND/AIMS: Patients with diabetic nephropathy have a high cardiovascular mortality. Epoetin beta pegol (continuous erythropoietin receptor activator, C.E.R.A.) is a drug for the treatment of renal anemia. In this study, we investigated the effect of C.E.R.A. on vascular endothelial function as...
Na minha lista:
| Publicado no: | Cardiovasc Ther |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5363236/ https://ncbi.nlm.nih.gov/pubmed/28054454 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1755-5922.12250 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|